查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1547522

全球热疗癌症治疗市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Hyperthermia Cancer Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

全球热疗癌症治疗市场的市场规模预计将从 2023 年的 1.8699 亿美元达到 2032 年的近 3.3098 亿美元，2024-2032 年研究期间复合年增长率为 6.55%。

热疗癌症治疗是利用热能破坏和杀死癌细胞的热疗法。身体组织暴露在高达 113°F 的高温下。透过这样做，癌细胞可能会缩小肿瘤。热疗的有效性取决于治疗期间达到的温度、治疗时间以及细胞和组织特征。热疗癌症治疗可单独或与化疗和放射治疗合併进行。

市场动态

全球热疗癌症治疗市场正处于起步阶段。全球癌症负担的增加以及对其有效性的研究预计将推动对热疗癌症治疗的需求。癌症是主要死亡原因，2020 年将导致近 1000 万人死亡。许多临床试验已经检验了热疗与化疗和放射治疗的结合。该研究取得了有利于商业用途的改进和进步结果，为市场创造了利润丰厚的机会。然而，热疗可能会使一些癌细胞对辐射更加敏感，导致皮肤不适或局部疼痛、水泡，有时甚至烧伤，从而抑制市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球热疗癌症治疗市场的各个细分市场进行了包容性评估。热疗癌症治疗产业的成长和趋势为本研究提供了整体方法。

市场区隔

热疗癌症治疗市场报告的这一部分提供了有关国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

依设备类型

  • 红外线热疗仪
  • 超音波热疗仪
  • 微波热疗设备
  • 其他的

依治疗方法

  • 局部方法（外部和间质、腔内或腔内方法、连续高温腹膜灌注 (CHPP)、深层组织和区域灌注）
  • 全身

按申请

  • 乳癌
  • 肝癌
  • 软组织肉瘤
  • 头颈肿瘤
  • 摄护腺癌
  • 其他的

按最终用户

  • 医院和专科诊所
  • 门诊手术中心
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲热疗癌症治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。热疗癌症治疗市场的主要参与者包括 Pyrexar Medical、Celsius42 GmbH、Hydrosun GmbH、Oncotherm Kft、Andromedic SRL、YamamotVinita Co. Ltd.、重庆海扶医疗科技有限公司、InnoMedicus Ltd.、Gamida、RanD。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：热疗癌症治疗 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按设备类型分類的市场吸引力分析
    • 按处理方法进行的市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球热疗癌症治疗市场分析：按设备类型

  • 按设备类型概述
  • 按设备类型进行历史和预测资料分析
  • 红外线热疗仪
  • 超音波热疗仪
  • 微波热疗设备
  • 其他的

第 6 章：全球热疗癌症治疗市场分析：依治疗方法分类

  • 依治疗方法概述
  • 依处理方法进行历史和预测资料分析
  • 局部方法（外部和间质、腔内或腔内方法、连续高温腹膜灌注 (CHPP)、深层组织和区域灌注）
  • 全身

第 7 章：全球热疗癌症治疗市场分析：按应用分类

  • 概述：按应用
  • 历史和预测数据分析：按应用
  • 乳癌
  • 肝癌
  • 软组织肉瘤
  • 头颈肿瘤
  • 摄护腺癌
  • 其他的

第 8 章：全球热疗癌症治疗市场分析：依最终使用者分类

  • 最终用户概述
  • 最终用户的历史和预测数据分析
  • 医院和专科诊所
  • 门诊手术中心
  • 其他的

第 9 章：全球热疗癌症治疗市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：热疗癌症治疗公司的竞争格局

  • 热疗癌症治疗市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Pyrexar Medical
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Celsius42 GmbH
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Hydrosun GmbH
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Oncotherm Kft
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Andromedic SRL
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • YamamotVinita Co. Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Chongqing Haifu Medical Technology Co. Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • InnoMedicus Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Gamida
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • RanD
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR11215080

The global demand for Hyperthermia Cancer Treatment Market is presumed to reach the market size of nearly USD 330.98 Million by 2032 from USD 186.99 Million in 2023 with a CAGR of 6.55% under the study period 2024-2032.

Hyperthermia cancer treatment is thermotherapy in which cancer cells are damaged and killed using thermal energy. The body tissues are exposed to high temperatures of up to 113°F. By doing this, cancer cells may shrink tumors. The effectiveness of hyperthermia therapy is dependent on the temperature achieved during the treatment, length of treatment, and cell and tissue characteristics. Hyperthermia cancer treatment is carried out alone or in combination with chemotherapy and radiation therapy.

MARKET DYNAMICS

The global hyperthermia cancer treatment market is at its nascent stage. Mounting cancer burden worldwide and spurring research on its effectiveness is projected to propel the demand for hyperthermia cancer treatment. Cancer is the primary cause of death, accounting for nearly 10 million deaths in 2020. The cancer prevalence increases every day with rising alcohol & tobacco consumption, exposure to ultraviolet radiation, and an unhealthy lifestyle. Numerous clinical trials have examined hyperthermia in combination with chemotherapy and radiation therapy. The research has witnessed improved and progressive results favorable for commercial use, creating lucrative opportunities for the market. However, hyperthermia treatment may make some cancer cells more sensitive to radiation, cause skin discomfort or local pain, blisters, and sometimes burns, restraining market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Hyperthermia Cancer Treatment. The growth and trends of Hyperthermia Cancer Treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Hyperthermia Cancer Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Device Type

  • Infrared Hyperthermia Devices
  • Ultrasound Hyperthermia Devices
  • Microwave Hyperthermia Devices
  • Others

By Treatment Method

  • Locoregional Method (External & Interstitial, Intraluminal or Endocavitary Methods, Continuous Hyperthermic Peritoneal Perfusion (CHPP), Deep Tissue & Regional Perfusion)
  • Whole-body

By Application

  • Breast Cancer
  • Liver Cancer
  • Soft Tissue Sarcoma
  • Head & Neck Tumors
  • Prostate Cancer
  • Others

By End User

  • Hospitals & Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Hyperthermia Cancer Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Hyperthermia Cancer Treatment market include Pyrexar Medical, Celsius42 GmbH, Hydrosun GmbH, Oncotherm Kft, Andromedic S.R.L., YamamotVinita Co. Ltd., Chongqing Haifu Medical Technology Co. Ltd., InnoMedicus Ltd., Gamida, RanD. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. HYPERTHERMIA CANCER TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Device Type
    • 3.7.2 Market Attractiveness Analysis By Treatment Method
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End User
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET ANALYSIS BY DEVICE TYPE

  • 5.1. Overview By Device Type
  • 5.2. Historical and Forecast Data Analysis By Device Type
  • 5.3. Infrared Hyperthermia Devices Historic and Forecast Sales By Regions
  • 5.4. Ultrasound Hyperthermia Devices Historic and Forecast Sales By Regions
  • 5.5. Microwave Hyperthermia Devices Historic and Forecast Sales By Regions
  • 5.6. Others Historic and Forecast Sales By Regions

6. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET ANALYSIS BY TREATMENT METHOD

  • 6.1. Overview By Treatment Method
  • 6.2. Historical and Forecast Data Analysis By Treatment Method
  • 6.3. Locoregional Method (External & Interstitial, Intraluminal or Endocavitary Methods, Continuous Hyperthermic Peritoneal Perfusion (CHPP), Deep Tissue & Regional Perfusion) Historic and Forecast Sales By Regions
  • 6.4. Whole-body Historic and Forecast Sales By Regions

7. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Breast Cancer Historic and Forecast Sales By Regions
  • 7.4. Liver Cancer Historic and Forecast Sales By Regions
  • 7.5. Soft Tissue Sarcoma Historic and Forecast Sales By Regions
  • 7.6. Head & Neck Tumors Historic and Forecast Sales By Regions
  • 7.7. Prostate Cancer Historic and Forecast Sales By Regions
  • 7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET ANALYSIS BY END USER

  • 8.1. Overview By End User
  • 8.2. Historical and Forecast Data Analysis By End User
  • 8.3. Hospitals & Specialty Clinics Historic and Forecast Sales By Regions
  • 8.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE HYPERTHERMIA CANCER TREATMENT COMPANIES

  • 10.1. Hyperthermia Cancer Treatment Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF HYPERTHERMIA CANCER TREATMENT INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Pyrexar Medical
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Celsius42 GmbH
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Hydrosun GmbH
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Oncotherm Kft
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Andromedic S.R.L.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. YamamotVinita Co. Ltd.
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Chongqing Haifu Medical Technology Co. Ltd.
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. InnoMedicus Ltd.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Gamida
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. RanD
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Device Type (USD MN)
  • Infrared Hyperthermia Devices Market Sales By Geography (USD MN)
  • Ultrasound Hyperthermia Devices Market Sales By Geography (USD MN)
  • Microwave Hyperthermia Devices Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Treatment Method (USD MN)
  • Locoregional Method (External & Interstitial, Intraluminal or Endocavitary Methods, Continuous Hyperthermic Peritoneal Perfusion (CHPP), Deep Tissue & Regional Perfusion) Market Sales By Geography (USD MN)
  • Whole-body Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Breast Cancer Market Sales By Geography (USD MN)
  • Liver Cancer Market Sales By Geography (USD MN)
  • Soft Tissue Sarcoma Market Sales By Geography (USD MN)
  • Head & Neck Tumors Market Sales By Geography (USD MN)
  • Prostate Cancer Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End User (USD MN)
  • Hospitals & Specialty Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Hyperthermia Cancer Treatment Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Hyperthermia Cancer Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Hyperthermia Cancer Treatment Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Device Type
  • Market Attractiveness Analysis By Treatment Method
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Device Type (USD MN)
  • Infrared Hyperthermia Devices Market Sales By Geography (USD MN)
  • Ultrasound Hyperthermia Devices Market Sales By Geography (USD MN)
  • Microwave Hyperthermia Devices Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Treatment Method (USD MN)
  • Locoregional Method (External & Interstitial, Intraluminal or Endocavitary Methods, Continuous Hyperthermic Peritoneal Perfusion (CHPP), Deep Tissue & Regional Perfusion) Market Sales By Geography (USD MN)
  • Whole-body Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Breast Cancer Market Sales By Geography (USD MN)
  • Liver Cancer Market Sales By Geography (USD MN)
  • Soft Tissue Sarcoma Market Sales By Geography (USD MN)
  • Head & Neck Tumors Market Sales By Geography (USD MN)
  • Prostate Cancer Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End User (USD MN)
  • Hospitals & Specialty Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.